Mass Medical Angels
Angel Group/Syndicate
Active
Brookline, United States
28
4M
17
0.39
3
- Stages of investment
- Areas of investment
Summary
The main department of described VC is located in the Boston. The venture was found in North America in United States.
The higher amount of exits for fund were in 2012. The usual things for fund are deals in the range of 5 - 10 millions dollars. The top activity for fund was in 2013. The fund is constantly included in less than 2 investment rounds annually. Comparing to the other companies, this Mass Medical Angels performs on 21 percentage points less the average number of lead investments.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Mass Medical Angels, startups are often financed by Cherrystone Angel Group, Maine Angels, Oleg Uritsky. The meaningful sponsors for the fund in investment in the same round are LaunchPad Venture Group, Boston Harbor Angels, Beacon Angels. In the next rounds fund is usually obtained by Maine Angels, Cherrystone Angel Group, Beta Fund.
This organization was formed by Carl Berke, Pushwaz Virk, Richard Anders, Roger Kitterman. We also calculated 7 valuable employees in our database.
The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. We can highlight the next thriving fund investment areas, such as Personal Health, Clinical Trials. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Daktari Diagnostics, InfoBionic, Capillary Biomedical. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 28
- Lead investments
- 0
- Exits
- 3
- Follow on index
- 0.39
- Investments by industry
- Biotechnology (17)
- Health Care (16)
- Medical Device (11)
- Therapeutics (11)
- Medical (4) Show 17 more
- Investments by region
-
- United States (25)
- Australia (2)
- Israel (1)
- Peak activity year
- 2011
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 3M
- Group Appearance index
- 0.96
- Avg. company exit year
- 4
- Avg. multiplicator
- 2.41
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Astrocyte Pharmaceuticals | 06 Jun 2018 | Biotechnology, Pharmaceutical, Therapeutics, Clinical Trials | Seed | 2M | United States, Massachusetts, Cambridge |
| Gallant Pet | 15 Mar 2018 | Biotechnology, Therapeutics, Pet | Seed | 0 | United States, California, San Diego |
| MoMelan Technologies | 11 May 2011 | Biotechnology, Health Care, Medical Device | Early Stage Venture | United States, Massachusetts, Cambridge |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.